Global Pharmaceuticals & Biotech Blue chip stocks

Revvity

Market Cap: US$12.8b

Provides health sciences solutions, technologies, and services.

Revolution Medicines

Market Cap: US$41.9b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Biogen

Market Cap: US$30.5b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Bayer

Market Cap: €48.4b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Akeso

Market Cap: HK$88.5b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Waters

Market Cap: US$39.3b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Charles River Laboratories International

Market Cap: US$12.7b

Charles River Laboratories International, Inc.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$121.4b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Elanco Animal Health

Market Cap: US$13.1b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Swedish Orphan Biovitrum

Market Cap: SEK 153.1b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Natera

Market Cap: US$39.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Axsome Therapeutics

Market Cap: US$11.0b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.6b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

ICON

Market Cap: US$12.6b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$30.6b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$11.9b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Sartorius Stedim Biotech

Market Cap: €16.9b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Galderma Group

Market Cap: CHF 41.6b

Operates as a dermatology company worldwide.

Insmed

Market Cap: US$21.5b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Takeda Pharmaceutical

Market Cap: JP¥8.7t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.

Viatris

Market Cap: US$20.6b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Eurofins Scientific

Market Cap: €12.1b

Provides various analytical testing and laboratory services worldwide.

WuXi Biologics (Cayman)

Market Cap: HK$169.8b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

Lonza Group

Market Cap: CHF 39.2b

Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

BeOne Medicines

Market Cap: US$37.2b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Sandoz Group

Market Cap: CHF 29.5b

Develops, manufactures, and markets generic and biosimilars worldwide.

Royalty Pharma

Market Cap: US$33.3b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Daiichi Sankyo Company

Market Cap: JP¥4.8t

Manufactures and sells pharmaceutical products in Japan and internationally.

Merck

Market Cap: US$317.0b

Operates as a healthcare company worldwide.

Neurocrine Biosciences

Market Cap: US$16.4b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Sino Biopharmaceutical

Market Cap: HK$87.8b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Cipla

Market Cap: ₹1.2t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Innovent Biologics

Market Cap: HK$158.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

CSL

Market Cap: AU$63.4b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

argenx

Market Cap: €46.8b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Gilead Sciences

Market Cap: US$163.5b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.